BackhedF, DingH, WangTThe gut microbiota as an environmental factor that regulates fat storage.Proc Natl Acad Sci U S A.2004; 101: 15718–23.
2.
TurnbaughPJ, LeyRE, MahowaldMA, MagriniV, MardisER, GordonJI. An obesity-associated gut microbiome with increased capacity for energy harvest.Nature.2006; 444: 1027–31.
3.
LeyRE, BackhedF, TurnbaughP, LozuponeCA, KnightRD, GordonJI. Obesity alters gut microbial ecology.Proc Natl Acad Sci U S A.2005; 102: 11070–5.
4.
LeyRE, TurnbaughPJ, KleinS, GordonJI. Microbial ecology: human gut microbes associated with obesity.Nature.2006; 444: 1022–3.
EisemanB, SilenW, BascomGS, KauvarAJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis.Surgery.1958; 44: 854–9.
7.
JarvisWR, SchlosserJ, JarvisAA, ChinnRY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.Am J Infect Control.2009; 37: 263–70.
8.
KhorutsA, DicksvedJ, JanssonJK, SadowskyMJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea.J Clin Gastroenterol.2010; 44: 354–60.
9.
HamiltonMJ, WeingardenAR, SadowskyMJ, KhorutsA. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.Am J Gastroenterol.2012; 107: 761–7.
10.
KellyCR, KundeSS, KhorutsA. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies.Clin Gastroenterol Hepatol2013.
11.
AngelbergerS, ReinischW, MakristathisATemporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.Am J Gastroenterol.2013; 108: 1620–30.
12.
KumpPK, GrochenigHP, LacknerSAlteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.Inflamm Bowel Dis.2013; 19: 2155–65.
13.
YatsunenkoT, ReyFE, ManaryMJHuman gut microbiome viewed across age and geography.Nature.2012; 486: 222–7.
14.
PetrofEO, GloorGB, VannerSJStool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut.Microbiome.2013; 1: 1–12.
15.
BlaserMJ, FalkowS. What are the consequences of the disappearing human microbiota?Nat Rev Microbiol.2009; 7: 887–94.
16.
HoffmannDE, FraserCM, PalumboFBScience and regulation. Probiotics: finding the right regulatory balance.Science.2013; 342: 314–5.
17.
VinderolaG, BinettiA, BurnsP, ReinheimerJ. Cell viability and functionality of probiotic bacteria in dairy products.Front Microbiol.2011; 2: 70.
18.
GrzeskowiakL, IsolauriE, SalminenS, GueimondeM. Manufacturing process influences properties of probiotic bacteria.Br J Nutr.2011; 105: 887–94.